Influenza continues to contribute to a significant number of serious respiratory diseases yearly, especially in the very young, elderly and those persons considered to be "high risk." InclUded in the "high risk" category are persons with chronic cardiovascular, pulmonary, renal, metabolic, or immune disorders (CDC, 1985) .
Influenza is responsible for yearly epidemics causing fever, cough, sore throat, headache, myalgia, and malaise (Goodman, 1980) . The highly contagious nature of influenza contributes to the high morbidity and mortality associated with the disease. As health care practitioners, it is of utmost importance to recognize certain control measures that can be applied to curtail and prevent further spread of influenza.
INFLUENZA VIRUS
Influenza virus is a member of the Orthomyxoviridae family (Belshe, 1984) . There are three major types of influenza virus; A, B, and C. Types A and B are primarily responsible for epidemics; type C is rarely isolated (Monto, 1983) . The virus contains an RNA core which is enveloped by two different antigens: hemagglutinin (H) and neuraminidase (N). These anti· gens have spike-like appearances on the virus membrane and are responsible for the subtypes of influenza A virus (Valenti, 1984) .
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Each type of virus periodically undergoes structural changes. Antigenic "drift" refers to the gradual change of the composition of the two surface antigens. Antigenic "shift" refers to a sudden and major change of the surface antigens. These changes are what determine the potential degree of spread of influenza during each season. For example, when an antigenic shift occurred, world-wide epidemics developed since the majority of the population did not have protective antibody (Monto, 1983) .
CLINICAL ILLNESS
The influenza virus is spread via droplet method (coughing, sneezing, talking) (Heggie, 1983) . It is also known that dried respiratory secretions containing virus can live on fomites for up to 24 hours. The virus thrives in cold environments which makes winter the ideal season for epidemics to occur. The disease generally attacks children and young adults with an abrupt onset. The characteristic symptoms are fever, chills, myalgia, malaise, headache, rhinorrhea, cough, and sore throat. The incubation period is generally 18 to 72 hours; however, it can be as long as four days with the duration of illness lasting up to seven days. Complete recovery may take several weeks to occur (Belshe, 1984) .
The mortality of influenza is directly associated with the complications that can occur at the time of illness. Persons who are likely to develop complications are infants under the age of one year and adults who are classified in the "high risk" category (Good-man, 1980) . Young healthy edults, however, are certainly not immune from developing complications.
The most devastating complication of influenza is pneumonia. Pneumonia develops as a response to the viral infection or to the invasion of secondary bacterial organisms such as with staphylococci or pneumococci. Other complications include myocarditis, pericarditis, meningitis, encephalitis, Reye syndrome, and Gullain-Barre syndrome (Belshe, 1984) .
PREVENTION AND MANAGEMENT
The key to controlling influenza remains prevention, with the focus being aimed primarily at individuals considered to be at greater risk of developing complications associated with influenza.
The WHO (World Health Organization), based on epidemiology data, yearly make available the influenza vaccine. The vaccine is composed of the strains of influenza that are anticipated to circulate. The new vaccine is available each fall with the expiration date being June 30 of the following year (CDC, 1985) . It is important that all partially or unused vaccine from the previous year be discarded as the strains of influenza that circulate vary from year to year.
Influenza vaccine should be administered annually by intramuscular injection, and the dose is directly related to age (Table) (CDC, 1985) . The vaccine is contraindicated for those individuals who have type I allergy to eggs and to those individuals who present at time of vaccination with an acute febrile illness. Individu-AAOHN JOURNAL als with acute febrile illness should not be Immunized until the symptoms have ended (CDC, 1985) .
Adverse reactions that can be anticipated after receiving influenza vaccine include fever, malaise, and myalgia (CDC, 1985) .
In addition to the listed target groups, the public health service recommends that influenza vaccine should be made readily available to the general pubflc (CDC, 1985) . Education is a key factor in contributing to the Implementation of successful vaccination programs. Physicians' offices, clinics, chronic care facilities, and hospitals are among the major areas where information regarding immunization should be made available. Schools and institutions where there are large numbers of employees should also be prepared to educate, immunize, and detect influenza.
Once influenza Is isolated in a community, vaccination can still be offered, especially to those individuals who are "high risk"; however, this
Influenza virus thrives in cold environments, making winter the ideal season for epidemics.
needs to be expedited early during an outbreak (CDC, 1985) .
Amantadine hydrochloride (Sym-metrel®) is the only drug available for treatment of influenza A. There is no licensed drug available for treatment of Influenza B. Amantadine has been shown to reduce symptoms of influenza and also decrease the duration of illness. Therefore, amantadine is an option that can be considered for treatment of influenza. Amantadine can also be offered as prophvlexls to those individuals who have not been vaccinated. Amantadine is 70%-90% effective in preventing influenza ill· ness.Therapy must be instituted before or soon after an individual has had contact with influenza to be effective (CDC, 1985) .
The appropriate dosage of ernentadine is 200 mg per day for healthy adults <65 years of age. The dose can be spilt to 100 mg twice per day to minimize adverse reactions. 
AMERICAN ASSOCIATION OF OCCUPATIONAL HEALTH NURSES
The American Association of Occupational Health Nurses is the professional association for registered nurses who provide on-the-job health care for the nation's workers. AAOHN serves as an advocate for occupational health nursing, establishes standards of practice and assists the occupational health nurse in provtdlng quality health care. AAOHN has approximately 170 local, state and regional constituent associations nationwide. AAOHN has made a commitment for excellence by developing a strong association to serve an important profession. 100 mg per day. For children, the dose is determined by age and weight. For individuals who have renal disease, the dose is based on creatinine clearance levels since the drug is excreted via the kidneys. Although adverse reactions are rare, they do occasionally occur. They include insomnia, light headedness, irritability, and difficulty concentrating. Amantadine should be used cautiously in the elderly and in individuals with renal disease. If adverse reactions do occur, the drug should be discontinued immediately (CDC, 1985) .
CONCLUSION
It must be stressed that the focus in the management of influenza continues to be prevention via the implementation of successful immunization programs. Immunization is known to be the most effective means in preventing influenza illness. Education in terms of the epidemiology of influenza, the availability of influenza vaccine, target groups to be considered RN, pp. 60-63. Monto, A. (1983, Dec.) . Prevention and drug treatment of influenza. American FamilyPhysician, pp. 165-169. Valenti, W. (1984, 32:2) . Influenza: Prevention and therapy. Henry Ford Hospital Medical Journal, pp. 99-100.
